Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prophylactic topical steroid for enfortumab vedotin–related cutaneous toxicity
jRCTs051240214Recruiting
- Sponsor
- Astellas Pharma
- Start
- Feb 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of clobetasol in transitional cell carcinoma (TCC) (2 arms), sponsored by Astellas Pharma. Started Feb 2025; status: recruiting.
02
Drugs
clobetasol
03
Conditions
transitional cell carcinoma (TCC)
Beyond the preview
Go deeper on jRCTs051240214.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs051240214.